Syneron Medical (NASDAQ:ELOS) is an Israel-based company that manufactures and distributes medical aesthetic devices powered by its proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. In the last one year, the shares of Syneron have traded between a low of $7.21 and a high of $11.92. Given Syneron's leadership position in the aesthetic devices market and its recently announced joint venture with Unilever (NYSE:UL), I feel the stock is meaningfully undervalued at its current level.
Syneron is a global leader in aesthetic devices with 28% worldwide market share. The company's highly innovative ELOS (Electro-Optical Synergy) technology provides the foundation for effective, safe and cost-effective tools that help physicians offer long-lasting...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|